PHYTO

Phyto Chem (India) financials

Market cap
₹10 Cr

Quarterly results

Q1 FY27: revenue down 98.0%, net profit down 87.5% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue4 4 1 2 4 −0%3 −19%0 −84%0 −98%
EBITDA1 0 -1 -1 -0 −179%-0 −247%-1 +37%-1 −2%
Net profit0 2 -1 -0 -1 −609%-0 −132%-0 +76%-1 −88%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance −37.0% 1Y

₹20.0₹25.0₹30.0Sept 25Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26

1Y: ₹27.78 on 9 Sept 2025 → ₹17.5. High ₹32.28 (21 Nov 2025), low ₹16.75 (9 Sept 2026).

Financials, as filed

Revenue fell 21.8% a year over 2 years, FY24 to FY26. Operating margin widened to -20.6%.

Year endingFY24FY25FY26
Revenue₹15 Cr₹14 Cr₹9 Cr
Operating profit₹-3 Cr₹-1 Cr₹-2 Cr
Operating margin-22.1%-9.5%-20.6%
Interest₹2 Cr₹2 Cr₹2 Cr
Depreciation₹0 Cr₹0 Cr₹0 Cr
Net profit₹-3 Cr₹-1 Cr₹-2 Cr
Net margin-22.6%-7.1%-19.9%
Cash from operations₹3 Cr₹2 Cr₹1 Cr
Free cash flow₹3 Cr₹2 Cr₹1 Cr
ROCE-4.9%3.3%-1.6%
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr
Reserves₹6 Cr₹6 Cr₹6 Cr₹3 Cr₹1 Cr₹0 Cr
Borrowings₹21 Cr₹21 Cr₹19 Cr₹18 Cr₹15 Cr₹20 Cr
Other liabilities₹14 Cr₹7 Cr₹10 Cr₹6 Cr₹5 Cr₹3 Cr
Total liabilities₹45 Cr₹38 Cr₹40 Cr₹32 Cr₹25 Cr₹28 Cr
Fixed assets₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr
Capital work in progress₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Investments₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Other assets₹42 Cr₹35 Cr₹37 Cr₹29 Cr₹23 Cr₹26 Cr
Total assets₹45 Cr₹38 Cr₹40 Cr₹32 Cr₹25 Cr₹28 Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Jun 2026

Since Jun 2025, the public added +4.64 pp while the government trimmed −4.63 pp.

Promoters
40.4%
DIIs
0.2%
Public
59.4%

Since Jun 2025

  • Public +4.64 pp
  • Government −4.63 pp
  • Promoters 0.00 pp

How it drifted, 12 quarters

Over this window the government fell from 4.6% to 0.0% — −4.6 pp.

Sep '23Dec '24Jun '26

Ownership split by quarter, oldest first. Sep '23: Promoters 40.4%, DIIs 0.2%, Government 4.6%, Public 54.8%.Dec '23: Promoters 40.4%, DIIs 0.2%, Government 4.6%, Public 54.8%.Mar '24: Promoters 40.4%, DIIs 0.2%, Government 4.6%, Public 54.8%.Jun '24: Promoters 40.4%, DIIs 0.2%, Government 4.6%, Public 54.8%.Sep '24: Promoters 40.4%, DIIs 0.2%, Government 4.6%, Public 54.8%.Dec '24: Promoters 40.4%, DIIs 0.2%, Government 4.6%, Public 54.8%.Mar '25: Promoters 40.4%, DIIs 0.2%, Government 4.6%, Public 54.8%.Jun '25: Promoters 40.4%, DIIs 0.2%, Government 4.6%, Public 54.8%.Sep '25: Promoters 40.4%, DIIs 0.2%, Government 4.6%, Public 54.8%.Dec '25: Promoters 40.4%, DIIs 0.2%, Public 59.4%.Mar '26: Promoters 40.4%, DIIs 0.2%, Public 59.4%.Jun '26: Promoters 40.4%, DIIs 0.2%, Public 59.4%.

Who was buying across the market this quarter →

Who is on the register

Named in the Jun 2026 filing

Every holder of Phyto Chem (India) Ltd. above SEBI's 1% disclosure line, and what changed since Mar 2026.

HolderStakeChange
Nayudamma Yarlagadda 7.87%unchanged
Rama Devi Uppalapati 3.78%unchanged
Sreemannarayana Prathipati 2.91%unchanged
Sreemannarayana Yarlagadda 2.37%unchanged
Yarlagadda Janaki Ramaiah 2.26%unchanged
Yadlapalli Venkateswarlu 2.21%unchanged
Prathipati Akkamma 1.96%unchanged
Nagendram Maddukuri 1.76%unchanged
Nagaraja Prathipati 1.64%unchanged
Yarlagadda Prabhakara Rao 1.52%unchanged
Anjaneyulu Prathipati 1.50%unchanged
Yarlagadda Lakshmi Prasanna 1.28%unchanged

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.